Cape Verde vs Sur: HIV-positive TB patients on ART (antiretroviral therapy)
Cape Verde
100.0%
in 2024
Sur
82.0%
in 2024
Cape Verde rank
1st
Sur rank
2nd
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Cape Verde
- Sur
How they compare
Cape Verde currently reports 100.0% against 82.0% in Sur, a difference of 18.0%.
That makes Cape Verde's figure about 1.2 times Sur's.
Across all 14 years both countries report, Cape Verde has been ahead every year.
Cape Verde ranks 1st and Sur ranks 2nd of 144 countries.
Cape Verde has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Cape Verde | Sur | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 100.0% | 10.0% | 90.0% | Cape Verde |
| 2010s | 93.6% | 71.2% | 22.4% | Cape Verde |
| 2020s | 90.4% | 75.8% | 14.6% | Cape Verde |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Cape Verde or Sur?
- Cape Verde, at 100.0% against 82.0% in Sur as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Cape Verde and Sur?
- 18.0%, with Cape Verde ahead.
- How many years of comparable data are there for Cape Verde and Sur?
- 14 years are reported by both, from 2005 to 2024.
- How do Cape Verde and Sur rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Cape Verde ranks 1st and Sur ranks 2nd of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.